Suzette Delaloge
Breast medical oncologist from Gustave Roussy who chairs the board of France's Institut National du Cancer.
Overview
Suzette Delaloge is Chair (Présidente) of the Board of Directors of the Institut National du Cancer (INCa), the French national cancer agency, appointed in 2026. A medical oncologist at Gustave Roussy, she has led major breast cancer research including the MyPeBS trial of risk-based breast screening and Gustave Roussy's cancer prevention programme.
Pages like this
not linked directly; found by shared links- PersonSunil Lakhani
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonPriya Rastogi
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonIsabel T. Rubio
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonEva Ciruelos
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonDorraya El-Ashry
Shares Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonNicolas Scotté
Shares Institut National du Cancer and the tags leadership, cancer policy.
- PersonDonna McKay
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, breast cancer.
- PersonRebecca Dent
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.